Donald Northfelt
A Phase 1 Study Of PD-1 Inhibition With Pembrolizumab Combined With JAK2 Inhibition In Triple Negative Breast Cancer · Mayo Clinic College of Medicine and Science
Credentials: · · · · · ·
History
PresentA Phase 1 Study Of PD-1 Inhibition With Pembrolizumab Combined With JAK2 Inhibition In Triple Negative Breast Cancer · Mayo Clinic College of Medicine and Science
- 1988–1991
Hematology/Oncology University of California
- 1985–1988
Resident University of California
- 1981–1985
Research
Journal of Clinical Oncology · 1998 · First of 10 authors · Corresponding · 471 citations
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
New England Journal of Medicine · 2016 · 452 citations
Clinical Cancer Research · 2017 · 308 citations
24 papers
23 papers
19 papers
- EP
17 papers
16 papers · 5 as a resident
14 papers
13 papers
13 papers
Clinical trials
- 2017–2023
Principal investigator · Completed · Phase 1
Mayo Clinic
- 2012–2020
- 2009–2015
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Principal investigator · Terminated
Mayo Clinic
- 2007–2013
Principal investigator · Terminated · Phase 2
Mayo Clinic